HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Massimo Franchini Selected Research

Blood Coagulation Factors (Coagulation Factor)

3/2020Investigational drugs to treat hemophilia.
1/2020Advances in managing rare acquired bleeding disorders.
10/2016The safety of pharmacologic options for the treatment of persons with hemophilia.
10/2015Newer Hemostatic Agents.
6/2015Solvent/detergent-treated plasma: a tale of 30 years of experience.
1/2015Solvent/detergent plasma: pharmaceutical characteristics and clinical experience.
10/2014Current management of hemophilia B: recommendations, complications and emerging issues.
10/2013FEIBA versus NovoSeven in hemophilia patients with inhibitors.
10/2012Haemophilia B: current pharmacotherapy and future directions.
10/2012Paradoxical thrombosis part 1: factor replacement therapy, inherited clotting factor deficiencies and prolonged APTT.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Massimo Franchini Research Topics

Disease

117Hemorrhage
02/2022 - 05/2002
83Hemophilia A (Haemophilia)
03/2022 - 11/2003
41Thrombosis (Thrombus)
08/2021 - 08/2004
38Neoplasms (Cancer)
01/2022 - 01/2004
25COVID-19
05/2022 - 01/2020
24Venous Thromboembolism
01/2018 - 11/2007
22von Willebrand Diseases (von Willebrand's Disease)
01/2021 - 06/2002
20Infections
01/2022 - 05/2002
16Cardiovascular Diseases (Cardiovascular Disease)
12/2019 - 01/2008
13Venous Thrombosis (Deep-Vein Thrombosis)
01/2016 - 11/2003
11Thrombocytopenia (Thrombopenia)
08/2021 - 11/2002
11Thrombotic Thrombocytopenic Purpura
01/2021 - 01/2006
10Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2010 - 11/2002
9Autoimmune Diseases (Autoimmune Disease)
01/2022 - 03/2005
9Hemorrhagic Disorders (Hemorrhagic Diathesis)
10/2017 - 04/2006
9Thrombophilia
01/2016 - 01/2007
9Hemochromatosis (Bronze Diabetes)
11/2010 - 05/2003
8Wounds and Injuries (Trauma)
07/2017 - 10/2006
7Hemophilia B (Haemophilia B)
10/2016 - 10/2011
6Acute Coronary Syndrome
03/2013 - 12/2008
6Disseminated Intravascular Coagulation
06/2010 - 04/2004
6Vascular System Injuries
01/2010 - 01/2007
6Iron Overload
03/2008 - 01/2004
5Communicable Diseases (Infectious Diseases)
05/2022 - 03/2006
5Atrial Fibrillation
02/2022 - 04/2006
5Inflammation (Inflammations)
01/2022 - 08/2007
4Thromboembolism
02/2022 - 11/2008
4Liver Diseases (Liver Disease)
07/2019 - 08/2007
4Virus Diseases (Viral Diseases)
06/2015 - 01/2005
4Anemia
11/2010 - 03/2004
4Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
01/2010 - 08/2005
4Chronic Hepatitis C
06/2008 - 12/2004
4Lymphoma (Lymphomas)
07/2007 - 11/2005
4HIV Infections (HIV Infection)
01/2007 - 07/2003
3Pulmonary Embolism
01/2016 - 06/2015
3Stroke (Strokes)
01/2016 - 02/2009

Drug/Important Bio-Agent (IBA)

56Factor VIII (Coagulation Factor VIII)IBA
03/2022 - 11/2003
42Blood Coagulation Factors (Coagulation Factor)IBA
03/2020 - 05/2002
27AutoantibodiesIBA
01/2022 - 03/2005
27von Willebrand FactorIBA
02/2021 - 07/2006
22Hemostatics (Antihemorrhagics)IBA
01/2021 - 11/2004
20Factor VIIa (Activated Factor VII)IBA
01/2019 - 06/2005
20AnticoagulantsIBA
09/2016 - 04/2007
18IsoantibodiesIBA
01/2019 - 11/2006
17recombinant FVIIa (rFVIIa)FDA Link
09/2018 - 03/2005
17Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric
09/2018 - 06/2002
16ABO Blood-Group SystemIBA
02/2021 - 07/2012
16Pharmaceutical PreparationsIBA
01/2021 - 02/2004
14Blood Group Antigens (Blood Groups)IBA
01/2021 - 06/2007
13IronIBA
11/2017 - 05/2003
12Biological ProductsIBA
02/2016 - 08/2007
11Neutralizing AntibodiesIBA
05/2022 - 09/2018
11Fibrinogen (Factor I)FDA Link
09/2018 - 11/2003
11ThrombinFDA Link
06/2015 - 01/2007
9Monoclonal AntibodiesIBA
05/2022 - 04/2006
9Biomarkers (Surrogate Marker)IBA
02/2022 - 01/2008
9AntibodiesIBA
01/2022 - 06/2005
9Proteins (Proteins, Gene)FDA Link
02/2021 - 12/2005
9Prothrombin (Factor II)IBA
01/2019 - 01/2005
9Lipoprotein(a)IBA
09/2017 - 01/2007
7Factor IX (Coagulation Factor IX)FDA LinkGeneric
09/2018 - 01/2013
7Inosine Triphosphate (ITP)IBA
01/2010 - 11/2002
6AntithrombinsIBA
01/2016 - 01/2005
6thiamine triphosphorate (TTP)IBA
10/2015 - 01/2006
6Rituximab (Mabthera)FDA Link
07/2015 - 11/2005
5Heparin (Liquaemin)FDA LinkGeneric
01/2021 - 09/2005
5Tranexamic Acid (AMCA)FDA Link
01/2020 - 01/2011
5Factor V (Coagulation Factor V)IBA
09/2018 - 02/2005
5Protein CIBA
01/2016 - 11/2008
5factor V LeidenIBA
01/2016 - 01/2005
5Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
09/2014 - 06/2007
5von Willebrand factor drug combination factor VIIIIBA
01/2010 - 11/2003
5Blood Proteins (Serum Proteins)IBA
01/2010 - 01/2007
5InterferonsIBA
06/2008 - 04/2003
4Factor XI (Plasma Thromboplastin Antecedent)IBA
09/2018 - 11/2004
4Factor VII (Proconvertin)IBA
09/2018 - 02/2010
4Immunosuppressive Agents (Immunosuppressants)IBA
10/2017 - 01/2007
4AntigensIBA
07/2017 - 10/2008
4prothrombin complex concentrates (PPSB)IBA
10/2016 - 08/2006
4Vitamin KFDA Link
01/2016 - 10/2009
4Fibrinolytic Agents (Antithrombotic Agents)IBA
03/2015 - 02/2010
4fibrin fragment D (D-dimer)IBA
09/2014 - 01/2008
4Thromboplastin (Tissue Factor)IBA
07/2011 - 08/2007
4FibrinIBA
11/2010 - 04/2004
4Dacarbazine (DIC)FDA LinkGeneric
06/2010 - 04/2004
3Antiviral Agents (Antivirals)IBA
05/2022 - 01/2007
3VaccinesIBA
01/2022 - 04/2010
3Immunoglobulins (Immunoglobulin)IBA
01/2022 - 12/2005
3Glycoproteins (Glycoprotein)IBA
01/2021 - 10/2012
3C-Reactive ProteinIBA
12/2020 - 06/2008
3emicizumabIBA
11/2020 - 01/2019
3Factor XIII (Coagulation Factor XIII)IBA
09/2018 - 01/2007
3PlasminogenIBA
01/2016 - 08/2007
3Thalidomide (Thalomid)FDA Link
11/2015 - 11/2011
3Factor Xa (Coagulation Factor Xa)IBA
05/2015 - 04/2007

Therapy/Procedure

93Therapeutics
05/2022 - 06/2002
5Operative Surgical Procedures
02/2016 - 01/2005
4Drug Therapy (Chemotherapy)
10/2012 - 11/2005
4Blood Transfusion (Blood Transfusions)
02/2011 - 03/2007
3Central Venous Catheters
07/2015 - 08/2004